MYC and cancer: Our analysis uncovers a cross-regulatory loop among splicing factors involving protein–protein and splicing-mediated interactions and re-discovers MYC as the key pathway linking cancer driver mutations to splicing factor regulation, as well as G2M, E2F, and spermatogenesis as novel candidate regulatory pathways.